IRF5 and hepatocellular carcinoma: IRF5 expression and function in hepatocytes infected with HCV virus, HCV replicon cells, and human primary tissues from patients with HCV-positive and -negative HCC were examined and identified that IRF5 was a new negative regulator of HCV-associated HCC pathogenesis.